Synthesis of thiolated chitosans: Promising polymers for prolonged mucoadhesive drug delivery

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 670-678

  Sreenivas, S A ^a   Pai, K V ^b  

^a KLE College of Pharmacy   (India)

^b Department of Industrial Chemistry ^*  (India)

Author keywords

Cohesiveness; Derivatization; Disulfide bonds; In vivo; Mucoadhesion; Thiomers

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BACITRACIN; BUSERELIN; CEFUROXIME AXETIL; CHITOSAN; CHITOSAN DERIVATIVE; CLOTRIMAZOLE; PEPTIDE DERIVATIVE; SALCATONIN;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DERIVATIZATION; DISULFIDE BOND; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; GELATION; HUMAN; MEAN RESIDENCE TIME; NONHUMAN; SYNTHESIS; TABLET MATRIX; VAGINITIS;

EID: 77953435840     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sreenivas S.A. and Pai K.V., Thiolated chitosans: novel polymers for mucoadhesive drug deliver - a review, Trop. J. of Pharm. Res., 2008, 7(3), 1077-1088.
2. Kast C.E. and Andreas B.S., Thiolated polymers - thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates, Biomaterials, 2001, 22, 2345-2352.
3. Felt O. Buri P. and Gurny R., Chitosan: a unique polysaccharide for drug delivery, Drug Dev. Ind. Pharm, 1998, 24, 979-993.
4. Fini A. and Orienti I., The role of chitosan in drug delivery, Am. J. Drug Deliv., 2003, 1, 43-59.
5. Takeuchi H. Yamamoto H. and Kawashima Y., Mucoadhesive nanoparticulate systems for peptide drug delivery, Adv. Drug Deliv. Rev., 2001, 47, 39-54.
6. Illum L. Farraj N.F. and Davis S.S., Chitosan as a novel nasal delivery system for peptide drugs, Pharm. Res., 1994, 11, 1186-1189.
7. Felt O. Furrer P. Mayer J.M. Plazonnet B. Buri P. and Gurny R., Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention, Int. J. Pharm., 1999, 180, 185-193.
8. Senel S. Kremer M. Kas S. Wertz P.W. Hincal A.A. and Squier C.A., Enhancing effect of chitosan on peptide drug delivery across buccal mucosa, Biomaterials, 2000, 21, 2067-2071.
9. Borchard G., Chitosans for gene delivery, Adv. Drug Deliv. Rev., 2001, 52, 145-150.
10. Liu W.C. and Yao K.D., Chitosan and its derivatives - a promising non-viral vector for gene transfection, J. Control. Rel., 2002, 83, 1-11.
11. Snyder G.H. Reddy M.K. Cennerazzo M.J. and Field D., Use of local electrostatic environments of cysteines to enhance formation of a desired species in a reversible disulfide exchange reaction, Biochim. Biophys. Acta., 1983, 749, 219-226.
12. Thanou M. Florea B.I. Langemeyer M.W. Verhoef J.C. and Junginger H.E., N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats), Pharm. Res., 2000, 17, 27-31.
13. Thanou M. Nihot M.T. Jansen M. Verhoef J.C. and Junginger J.C., Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in viv, J. Pharm. Sci., 2001, 90, 38-46.
14. Baumann H. and Faust V., Concepts for improved regioselective placement of O-sulfo, N-sulfo, N-acetyl, and N-carboxymethyl groups in chitosan derivatives, Carbohydr. Res., 2001, 331, 43-57.
15. Andreas B.S. and Krajicek M.E., Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates, J. Control. Rel., 1998, 50, 215-223.
16. Andreas B.S. and Hopf T.E., Synthesis and in vitro evaluation of chitosan-thioglycolic acid conjugates, Sci. Pharm, 2001, 69, 109-118.
17. Hornof M.D. Kast C.E. and Andreas B.S., In vitro evaluation of the viscoelastic behavior of chitosan - thioglycolic acid conjugates, Eur. J. Pharm. Biopharm., 2003, 55, 185-190.
18. Andreas B.S. Brandt U.M. and Clausen A.E., Synthesis and in vitro evaluation of chitosancysteine conjugates, Sci. Pharm., 1999, 67, 196-208.
19. Andreas B.S. Hornof M. and Zoidl T., Thiolated polymers - thiomers: modification of chitosan with 2-iminothiolane, Int. J. Pharm., 2003, 260, 229-237.
20. Roldo M. Hornof M. Caliceti P. and Andreas B.S., Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation, Eur. J. Pharm. Biopharm., 2004, 57(1), 115-21.
21. Krum K. Alexander H.K. Martin H.H. and Andreas B.S., Synthesis and in vitro evaluation of a novel thiolated chitosan, Biomaterials, 2005, 26, 819-826.
22. Krum K. Martin H. Martin W. and Andreas B.S., Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate, Biomaterials, 2006, 27, 127-135.
23. Langoth N. Guggi D. Pinter Y. and Andreas B.S., Thiolated Chitosan: In Vitro Evaluation of its Permeation Enhancing Properties, J. Control. Rel., 2004, 94(1), 177-86.
24. Kast C.E. Valenta C. Leopold M. and Andreas B.S., Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole, J. Control. Rel., 2002, 81, 347-354.
25. Leitner V.M. Marschutz M.K. and Andreas B.S., Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass, Eur. J. Pharm. Sci., 2003, 18, 89-96.
26. Leitner V.M. Walker G.F. and Andreas B.S., Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins, Eur. J. Pharm. Biopharm., 2003, 56, 207-214.
27. Artursson P. Lindmark T. Davis S.S. and Illum L., Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm. Res., 1994, 11, 1358-1361.
28. Borchard G. Luessen H.L. Boer A.G.D. Verhoef J.C. Lehr C.M. and Junginger H.E., The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosanglutamate and carbomer on epithelial tight junctions in vitro, J. Control. Rel., 1996, 39, 131-138.
29. Dodane V. Amin Khan M. and Merwin J.R., Effect of chitosan on epithelial permeability and structure, Int. J. Pharm., 1999, 182, 21-32.
30. Schipper N.G.M. Olsson S. Hoogstraate J.A. Boer A.G.D. Varum K.M. and Artursson P., Chitosans as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorption enhancement, Pharm. Res., 1997, 14, 923-929.
31. Schipper N.G.M. Varum K.M. Stenberg P. Ocklind G. Lennernas H. and Artursson P., Chitosans as absorption enhancers for poorly absorbable drugs. 3: Influence of mucus on absorption enhancement, Eur. J. Pharm. Sci., 1999, 8, 335-343.
32. Luessen H.L. Leeuw B.J.D. Langemeyer M.W. Boer A.G.D. Verhoef J.C. and Junginger H.E., Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo, Pharm. Res., 1996, 13, 1668-1672.
33. Clausen A.E. Kast C.E. and Andreas B.S., The role of glutathione in the permeation enhancing effect of thiolated polymers, Pharm. Res., 2002, 19, 602-608.
34. Barrett W.C. Gnore J.P.D. Konig S. Fales H.M. Keng Y.F. and Zhang Z.Y., Regulation of PTP1B via glutathionylation of the active site cysteine 215, Biochemistry, 1999, 38, 6699-6705.
35. Staddon J.M. Herrenknecht K. Smales C. Rubin L.L., Evidence that tyrosine phosphorylation may increase tight junction permeability, J. Cell Sci., 1995, 108, 609-619.
36. Grafstrom R. Stead A.H. and Orrenius S., Metabolism of extracellular glutathione in rat small-intestinal mucosa, Eur. J. Biochem., 1980, 106, 571-577.
37. Andreas B.S. Kast C.E. and Guggi D., Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/ GSH systems, J. Control. Rel., 2003, 93(2), 95-103.
38. Guggi D. Krauland A.H. and Andreas B.S., Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin, J. Control. Rel., 2003, 92, 125-135.
39. Torres-Lugo M. and Peppas N.A., Transmucosal delivery systems for calcitonin: a review, Biomaterials, 2001, 21, 1191-1196.
40. Edsman K. Carlfors J. and Petersson J., Rheological evaluation of poloxamer as an situ gel for ophthalmic use, Eur. J. Pharm. Sci., 1998, 6, 105-112.
41. Bromberg L.E., Enhanced nasal retention of hydrophobically modified polyelectrolytes, J. Pharm. Pharmacol., 2001, 53, 109-114.
42. Deasy P.B. and Quigley K.J., Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use, Int. J. Pharm., 1991, 73, 117-123.
43. Paulsson M. Hagerstrom H. and Edsman K., Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions, Eur. J. Pharm. Sci., 1999, 9, 99-105.
44. Lee Y.H. and Sinko P.J., Oral delivery of salmon calcitonin, Adv. Drug Deliv. Rev. 2000, 42, 225-238.
45. Shah R.B. Ahsan F. and Khan M.A., Oral delivery of proteins: progress and prognostication, Crit. Rev. Ther. Drug Carrier Syst., 2002, 19, 135-169.
46. Guggi D. and Andreas B.S., In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases, Int. J. Pharm., 2003, 252, 187-196.
47. Andreas B.S. and Scerbe-Saiko A., Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins, Pharm. Res., 1998, 15, 263-269.
48. Andreas B.S., Chitosan and its derivatives: potential excipients for peroral peptide delivery systems, Int. J. Pharm., 2000, 194, 1-13.
49. Guggi D. Kast C.E. and Andreas B.S., In vivo evaluation of an oral calcitonin delivery system for rats based on a thiolated chitosan matrix, Pharm. Res., 2003, 20(12), 1989-1994.